Astrazeneca (AZN) Free Cash Flow (2005 - 2026)
Astrazeneca (AZN) free cash flow from Dec 31, 2005 to Mar 31, 2026. The TTM Astrazeneca (AZN) free cash flow is $8.07B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Astrazeneca (AZN) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -11.70% |
| 3 Years TTM | +10.19% |
| 5 Years TTM | +15.68% |
| 10 Years TTM | +12.12% |
| All Time TTM | +1.25% |
Annual Free Cash Flow change of Astrazeneca (AZN)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | $1.82B | -79.00% |
| 2025 | $8.67B | +19.18% |
| 2024 | $7.28B | +10.78% |
| 2023 | $6.57B | -9.26% |
| 2022 | $7.24B | +92.32% |
| 2021 | $3.76B | +71.59% |
| 2020 | $2.19B | +330.84% |
| 2019 | $509M | -59.18% |
| 2018 | $1.25B | -36.31% |
| 2017 | $1.96B | +6.94% |
| 2016 | $1.83B | +241.60% |
| 2015 | $536M | -87.55% |
| 2014 | $4.31B | -19.39% |
| 2013 | $5.34B | +129.37% |
| 2012 | $2.33B | -64.30% |
| 2011 | $6.52B | -21.02% |
| 2010 | $8.26B | -5.94% |
| 2009 | $8.78B | +86.73% |
| 2008 | $4.70B | -19.34% |
| 2007 | $5.83B | -8.23% |
| 2006 | $6.35B | +244.95% |
| 2005 | $1.84B | N/A |
Comparison Astrazeneca (AZN) five years free cash flow CAGR with competitors
Astrazeneca (AZN) five years free cash flow CAGR is 15.68%.
| Ticker | Name | five years Free Cash Flow CAGR | Upside |
|---|---|---|---|
| LLY | Lilly(Eli) & Company | 21.25% | +35.53% |
| NVS | Novartis AG | 9.71% | -38.07% |
| SNY | Sanofi | 8.08% | -48.44% |
| MRK | Merck & Co Inc | 5.49% | -64.99% |
| GILD | Gilead Sciences Inc | 3.30% | -78.97% |
| ABBV | Abbvie Inc | 2.35% | -85.01% |